Bausch Health Files Confidentially for IPOs of Eye Care Business and Medical Aesthetics Business
Bausch Health has filed confidentially for the initial public offerings of its eye health business Bausch + Lomb, and its medical aesthetics business Global Solta, according to MarketWatch.
The company has not yet set terms for either deal, but expects them to completed on previously communicated timelines of the fourth quarter of 2021 or first half of 2022, based on market conditions.
